Evaluate

September 20, 2021

Pfizer/Biotech's Covid vaccine data looks good enough for FDA, but parents?

March 31, 2021

Pfizer’s Covid paediatric jab needs to win in the home as well as the clinic

February 18, 2021

How low can you go in Covid-19 vaccine trials?

January 14, 2021

J&J provides early hope for single-dose Covid-19 vaccine

Pivotal data for JNJ-78436735 are imminent, with Novavax and Curevac not far behind.

October 13, 2020

J&J pause adds to adenovirus vaccine doubts

Details are scant about the “unexplained illness” seen with Johnson & Johnson’s Covid-19 vaccine, but the news puts another dent in public confidence.

September 14, 2020

Upsizing and restarts: Covid vaccine trials rumble on

September 09, 2020

Covid vaccine developers face nervous wait

More details on an adverse event in a trial of Astrazeneca's AZD1222 will be needed to assess the fallout for other vaccine developers.

June 04, 2020

Have Glaxo and Sanofi been snubbed by Project Warp Speed?

May 19, 2020

Moderna reminds the markets of biotech’s dual purpose

On the back of coronavirus mania, Moderna, a $30bn company heavily funded by the US government, taps investors for $1.3bn.